Cancer Genomics and Proteomics
Country
Greece
Western Europe
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Biochemistry
Q2
└
Genetics
Q2
└
Medicine (miscellaneous)
Q2
SJR 2025
0.807
Q2
SJR Score
H-Index
53
Citations / Doc (2yr)
2.66
Total Docs. (latest)
76
Total Citations (3yr)
533
Publication type
Journals
ISSN
17906245, 11096535
Coverage
2004-2026
Journal Rank
#6,823
Subject Categories
Biochemistry
Q2
Genetics
Q2
Medicine (miscellaneous)
Q2
Cancer Research
Q3
Molecular Biology
Q3
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 76 |
| Total Docs. (3 years) | 183 |
| Total Refs. | 3,919 |
| Total Citations (3 years) | 533 |
| Citable Docs. (3 years) | 183 |
| Citations / Doc. (2 years) | 2.66 |
| Ref. / Doc. | 51.57 |
| % Female | 35.5% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Cancer Genomics and Proteomics?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Cancer Genomics and Proteomics has an SJR of 0.807 and is ranked Q2.
What is the SJR and quartile of Cancer Genomics and Proteomics?
Cancer Genomics and Proteomics has an SJR (SCImago Journal Rank) of 0.807 and its best quartile is Q2.
What is the H-index of Cancer Genomics and Proteomics?
The H-index of Cancer Genomics and Proteomics is 53, meaning 53 of its articles have each been cited at least 53 times.
Is Cancer Genomics and Proteomics indexed in Scopus?
Yes. Cancer Genomics and Proteomics is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.